临床药师干预对COPD患者吸入剂使用、自我管理及生活质量的影响  

Effect of Clinical Pharmacist Intervention on Inhalation Use,Self-Managementand Quality of Life in Patients with COPD

作　　者：林永春[1] 李琼[1] 曹熙 陈华玲 Lin Yongchun(Department of Clinical Pharmacy,Zhanjiang Central People’s Hospital,Zhanjiang Guangdong 524000)

机构地区：[1]广东省湛江市湛江中心人民医院药学部临床药学室,广东湛江524000

出　　处：《黑龙江医药》2023年第1期27-29,共3页Heilongjiang Medicine journal

基　　金：湛江市非资助科技攻关计划项目(项目编号:2021B01259)。

摘　　要：目的:探讨临床药师干预对COPD患者吸入剂使用、自我管理及生活质量的影响。方法:选取2020年8月-2021年10月于我院门诊或住院治疗的80例慢性阻塞性肺患者为研究样本,据随机数字表法分为观察组和对照组(各40例)。对照组接受常规干预,观察组给予临床药师干预,比较两组受试者的吸入装置操作评分、自我管理问卷评分、生活质量评分。结果:两组经过干预后,观察组吸入装置操作中打开装置上药得分、调整呼吸得分、吸入药品得分、关闭装置得分以及总分均高于对照组(P<0.05);观察组自我管理问卷中疾病认知得分、药物使用事项得分、不良反应了解得分以及总分均高于对照组(P<0.05);观察组生活质量四个维度社会功能评分、躯体功能评分、角色功能评分及认知功能评分均高于对照组(P<0.05)。结论:临床药师参与慢阻肺患者疾病教育和吸入剂使用技术指导中作用显著,改善患者自我管理能力,进一步提升患者生活质量,值得推广及深入探究。Objective:To investigate the effects of clinical pharmacists’intervention on inhalant use,self-management and quality of life in COPD patients.Methods:A total of 80 patients with COPD who received outpatient or inpatient treatment in our hospital from August 2020 to October 2021 were selected as study samples and divided into observation group and control group(40 cases each)according to random number table method.The control group received routine intervention,and the observation group received clinical pharmacist intervention.The inhalation device operation scores,self-management questionnaire scores and quality of life scores of subjects in the two groups were compared.Results:After intervention,the scores of opening the device,adjusting breathing,inhaling drugs,closing the device and total scores in the observation group were higher than those in the control group(P<0.05).The scores of disease cognition,drug use,adverse reaction understanding and total scores in self-management questionnaire in observation group were higher than those in control group(P<0.05).Social function score,physical function score,role function score and cognitive function score of four dimensions of quality of life in the observation group were higher than those in the control group(P<0.05).Conclusion:Clinical pharmacists’participation in disease education of COPD patients and technical guidance on inhalant use plays a significant role in improving patients’self-management ability and further enhancing patients’quality of life,which is worthy of promotion and in-depth exploration.

关 键 词：临床药师 慢性阻塞性肺 吸入装置操作 生活质量 

分 类 号：R563[医药卫生—呼吸系统]